Trial Profile
A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2021
Price :
$35
*
At a glance
- Drugs Tetrabenazine (Primary)
- Indications Huntington's disease
- Focus Therapeutic Use
- 18 Sep 2019 Planned End Date changed from 1 Jul 2019 to 1 Jul 2023.
- 18 Sep 2019 Planned primary completion date changed from 1 Jul 2019 to 1 Jul 2023.
- 06 Sep 2018 Planned End Date changed from 1 Jul 2018 to 1 Jul 2019.